Foldable Capsular Vitreous Body Implantation for Complicated Retinal Detachment Caused by Severe Ocular Trauma

Li, Meili; Tang, Yu; Li, Suyan; Zhang, Zhengpei; Guan, Lina; Li, Jie; Xu, Jing; Ji, Sujuan

doi:10.1097/iae.0000000000003493

Cited by 4 publications

(1 citation statement)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…To sum up, in severe retinal detachment treatment, FCVB implant is an effective new operation method, can control the eyeball atrophy, part of patients achieved retinal reattachment, and no severe complications, and some literature shown that it can also eliminate the psychological barriers, improve patient satisfaction, have great potential for clinical application [36][37][38][39].…”

Section: Discussionmentioning

confidence: 99%

Study on the efficacy and safety of foldable capsular vitreous body in the severe retinal detachment eyes

Zhao

Zhang

et al. 2022

BMC Ophthalmol

View full text Add to dashboard Cite

Background This study was to evaluate the efficacy and safety of the implantation of foldable capsular vitreous body (FCVB) in severe retinal detachment eyes. Methods A retrospective study in retinal detachment eyes was performed at Shandong Provincial Hospital Affiliated to Shandong First Medical University. A standard three-port pars plana vitrectomy was performed, and the FCVB was triple folded and implanted into the vitreous cavity. The silicone oil (SO) was then injected into the capsule of the FCVB to support the retina and eye. During the follow-up period, The treated eyes were examined by ophthalmoscopy, fundus photography, and tonometry. B-scan ultrasonography, optical coherence tomography (OCT), and computed tomography (CT), were also performed. Results From May 2020 to November 2021, 31 cases with severe retinal detachment were enrolled in the study. The postoperative follow-up time gradient ranged from 1 to 72 weeks, At various observation time points during the 72 weeks after surgery, The postoperative IOP was maintained at around 10 mmhg at various time points, with a slight decrease compared to the preoperative IOP (14.2 ± 4.6 mmHg n = 18), and was statistically significant. 9 of 31 patients had clear refractive media, both fundus and OCT showed retinal reattachment, OCT showed the 200 μm thick FCVB capsule support retina. The remaining 22 patients with unclear refractive media, B-scan showed arcuate hyperechoes in front of the retina. There was also no significant difference in visual acuity compared to preoperative. The FCVB was well positioned in the vitreous cavity, and no serious complications such as endophthalmitis, glaucoma, silicone oil emulsification, product exposure, or sympathetic uveitis were found. Conclusions FCVB has retinal support with certain ability to maintain IOP and eye morphology and avoid eye removal in patients with severe retinal detachment during the 72-week observation period.

show abstract

Section: Discussionmentioning

confidence: 99%